Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.

European markets closed lower on Wednesday, with traders monitoring corporate earnings and awaiting the Federal Reserve’s ...

Interim Management Statement covering Q3 2024/25 The Board of Directors of Rovsing A/S has today reviewed and approved the ...

With a profit before tax of DKK 39.1 million for Q1, the BANK of Greenland made a sound start to 2025. As expected, the result is affected by the declining level of interest rates, and is also below ...

As a licensed VASP under VARA’s globally recognized framework, DKK Digital is now authorized to offer a comprehensive suite ...

Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...

Nini Pryds, Henning Friis Poulsen, Irini Angelidaki, and Leif Oxenløwe each received a prestigious Villum Investigator grant, ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...

ABU DHABI – Agility Global PLC, a multi-business owner and operator and long-term investor, today reported Q1 2025 earnings ...